Axoft is a neurotechnology company developing next-generation neural interfaces using soft, flexible materials. The company focuses on creating brain-computer interfaces that are more biocompatible and less invasive than traditional rigid neural implants. Axoft's technology aims to enable better treatment of neurological conditions and advance brain-computer interface applications through their innovative soft neural interface platform.
Axoft has received investment from 1 venture capital firm.
Develops soft, flexible neural interfaces and implantable brain-computer interface technology.
Axoft has received investment from Castor Ventures. These venture capital firms and investors provide both capital and strategic support.
Axoft operates in the Biotech sector. Develops soft, flexible neural interfaces and implantable brain-computer interface technology.
